Valby, Denmark, 6 May 2014 – H. Lundbeck A/S (Lundbeck) hereby reports transactions made by executives and persons and legal entities closely associated to them with shares and linked securities in Lundbeck, cf. Section 28a of the Danish Securities Trading Act.
At Lundbeck’s Annual General Meeting held on 26 March 2014, a new incentive scheme for the Executive Management was approved by the shareholders. In connection with this new incentive scheme, the Board of Directors has granted the below warrants to the Executive Management. Each warrant grants the right to subscribe for one (1) share in Lundbeck. The calculation of the market price of the warrants is based on Black-Scholes.
| Name: | Ulf Arne Wiinberg |
| Job position: | President and CEO |
| ID code (ISIN code): | DK 0010287234 |
| Name of the issuer of the securities: | H. Lundbeck A/S |
| Description of the security: | Warrant |
| Nature of the transaction: | Grant of warrants |
| Date of trading: | 5 May 2014 |
| Market on which the trading was affected: | Nasdaq OMX Copenhagen |
| Number of traded securities: | 600,000 |
| Market price of securities traded (Black-Scholes): | DKK 15,630,997 |
| Name: | Anders Götzsche |
| Job position: | Executive Vice President and CFO |
| ID code (ISIN code): | DK 0010287234 |
| Name of the issuer of the securities: | H. Lundbeck A/S |
| Description of the security: | Warrant |
| Nature of the transaction: | Grant of warrants |
| Date of trading: | 5 May 2014 |
| Market on which the trading was affected: | Nasdaq OMX Copenhagen |
| Number of traded securities: | 360,000 |
| Market price of securities traded (Black-Scholes): | DKK 9,378,598 |
| Name: | Anders Gersel Pedersen |
| Job position: | Executive Vice President, Research and Development |
| ID code (ISIN code): | DK 0010287234 |
| Name of the issuer of the securities: | H. Lundbeck A/S |
| Description of the security: | Warrant |
| Nature of the transaction: | Grant of warrants |
| Date of trading: | 5 May 2014 |
| Market on which the trading was affected: | Nasdaq OMX Copenhagen |
| Number of traded securities: | 395,000 |
| Market price of securities traded (Black-Scholes): | DKK 10,290,405 |
Persons under obligation to report such transactions are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.
Closely associated persons/entities could include but is not limited to:
- spouse or cohabitant
- children below the age of 18, provided that the executive is the custody holder
- legal entities in which the executive has a controlling influence
Lundbeck contacts
| Investors: | Media: |
| Palle Holm Olesen | Mads Kronborg |
| Vice President, Investor Relations | Director, Media Relations |
| PALO@lundbeck.com | MAVK@lundbeck.com |
| +45 36 43 24 26 | +45 36 43 30 00 |
| Jens Høyer | |
| Specialist, Investor Relations | |
| JSHR@lundbeck.com | |
| +45 36 43 33 86 | |
About Lundbeck
H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in brain diseases. For more than 50 years, we have been at the forefront of research within neuroscience. Our development and distribution of pioneering treatments continues to make a difference to people living with brain diseases. Our key areas of focus are alcohol dependence, Alzheimer’s disease, depression/ anxiety, epilepsy, Huntington’s disease, Parkinson’s disease, schizophrenia and stroke.
Our approximately 6,000 employees in 57 countries are engaged in the entire value chain throughout research, development, production, marketing and sales, and are committed to improving the quality of life of people living with brain diseases. Our pipeline consists of several late-stage development programs and our products are available in more 100 countries. We have research centers in China, Denmark and the United States, and production facilities in China, Denmark, France, Italy and Mexico. Lundbeck generated revenue of DKK 15.3 billion in 2013 (EUR 2.0 billion; USD 2.7 billion).
Lundbeck’s shares are listed on the stock exchange in Copenhagen under the symbol ”LUN”. Lundbeck has a sponsored Level 1 ADR program listed in the US (OTC) under the symbol ”HLUYY”. For additional information, we encourage you to visit our corporate site www.lundbeck.com.
